0001225208-16-039042.txt : 20160908 0001225208-16-039042.hdr.sgml : 20160908 20160908094350 ACCESSION NUMBER: 0001225208-16-039042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160906 FILED AS OF DATE: 20160908 DATE AS OF CHANGE: 20160908 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeFord John A CENTRAL INDEX KEY: 0001403373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 161874959 MAIL ADDRESS: STREET 1: C R BARD INC STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2016-09-06 0000009892 BARD C R INC /NJ/ BCR 0001403373 DeFord John A C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Sr. VP Sci Tech and Clin Afrs Common Stock 2016-09-06 4 M 0 4161.0000 136.3700 A 25768.0174 D Common Stock 2016-09-06 4 M 0 3767.0000 168.8650 A 29535.0174 D Common Stock 2016-09-06 4 S 0 1261.0000 221.6440 D 28274.0174 D Common Stock 2016-09-06 4 S 0 6667.0000 220.9526 D 21607.0174 D Common Stock 71.2310 I 401(k) Plan Option (Right to Buy) 168.8650 2016-09-06 4 M 0 3767.0000 0.0000 D 2024-12-10 Common Stock 3767.0000 11302.0000 D Option (Right to Buy) 136.3700 2016-09-06 4 M 0 4161.0000 0.0000 D 2023-12-11 Common Stock 4161.0000 8322.0000 D Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Includes 0.1202 shares acquired under the Company's Dividend Reinvestment Plan from February 6, 2016 to July 29, 2016. Includes 0.002 shares acquired under the Company's Employee Stock Purchase Plan from February 6, 2016 to August 1, 2016. Represents the weighted average sales price for price increments ranging from $221.46 to $222.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $220.42 to $221.39. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 13.422 shares acquired under the Company's 401(k) Plan from February 6, 2016 to July 29, 2016. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Of this option grant 3,767 options vested on December 10, 2015 and the remaining options vest in three annual installments beginning on December 10, 2016. Of this option grant 4,161 options vested on December 11, 2015 and the remaining options vest in two annual installments beginning on December 11, 2016. Myra McGinley, Attorney-in-Fact 2016-09-08